Citius Pharma (CTXR) Video Presentation.
Chairman Leonard Mazur Discusses:
Mino-Lok Treatment for Infected Catheters.
Novellus Stem Cell Treatment for CoronaVirus and Acute Respiratory Distress. (This is not a vaccine folks, it...
Adding Dalrada (DFCO) $0.09 to CoronaVirus Stock Watch List.
LIVE QUOTE
Adding Dalrada (DFCO), a technology Incubator with interests in telehealth and hand sanitizers to the Watch List. Both sectors you're probably aware, are...
Shark Tanks’ Kevin Harrington Gets Into Sanitizer Business.
Aphex BioCleanse Systems Welcomes Original Shark Tank Investor Kevin Harrington and World-Renowned Entrepreneur Mark Timm as Advisors
PITTSFORD, N.Y. , Oct. 12, 2020 /PRNewswire/ --...
Adding Telehealth Play CB Scientific (CBSC) $1.10 to CoronaVirus Watch List.
MyCardia's My-Cam Offers At-Home Heart Rate Monitoring.
LIVE QUOTE
New client and a Telehealth play, studying now. Thinly, thinly traded. We like what we’ve read so...
Citius Pharma (CTXR) Shareholder Letter | Year Ahead Roadmap.
2021 and 2020 Milestones In Plain Sight.
Locked and Loaded for most of 2020 - many major milestone events lie around the corner for Citius...
Telehealth App Hapbee (HAPB) Goes Public and More.
1. Hapbee (HAPB) $0.30, Going Public.2. Saying Goodbye to Immunomedics (IMMU) $86.3. Adding Biosig (BSGM) $2.95, to Watch List.4. Dalrada (DFCO) $0.11, Cancer Screening Test...
Dalrada (DFCO) Announces Form S-1 Registration Declared Effective by SEC
SAN DIEGO , Nov. 3, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), is pleased to announce that its Form S-1 registration statement has been declared effective by...
Dalrada (DFCO) Removes Shell Company Status.
LIVE QUOTE
SAN DIEGO, Nov. 6, 2020
SAN DIEGO , Nov. 6, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), announced that it has filed Form 8-A12b with the U.S....
OMNIQ (OMQS) $5.00 Reports $15.8 Million 3Q, up 21%.
OMNIQ Corp. Reports Strong Sales of $15.8 Million for Third Quarter of 2020, up 21% Year over Year
Strong sequential revenue growth of 25 %...















